coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Victoria PCN, Stockport (LAD) · Health Inequalities Profile

    PCN U14006 · NHS Greater Manchester Integrated Care Board · 4 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    40,645

    Registered population

    63.4% aged 18–64

    16.6%

    Aged 65+

    ICB 14.9% · England 17.9%

    23.8%

    In IMD quintile 1

    ICB 40.7% · England 21.0%

    ~8,846

    Core20 residents (est.)

    Resident basis; registered basis ~9,249 · see page 3

    6,460

    Hypertension register

    +3.58% in 3 yrs · England +5.60%

    502

    SMI register

    15% of Stockport (LAD)'s

    1,012

    COPD register

    Reviews -8.13% in 3 yrs

    Forecast to 2030

    6,999

    Hypertension patients, 2030

    +539 on today

    75.7%

    QRISK ≥20% on statins, 2030

    +2.35pp over 3 yrs

    4.7%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    966
    Asthma review rate fell over three years.

    About 966 asthma patients lack a recorded review; completion is 67.5% (England 65.7%) after a 5.0% three-year fall (England +4.4%), which may reflect recall.

    70.8%
    Lipid therapy for high QRISK exceeds England.

    Lipid-lowering therapy reaches 70.8% of patients with QRISK ≥ 20% (England 63.6%, Stockport (LAD) 64.8%), although three-year growth was +3.4% against England's +6.2%.

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Older adults comprise 16.6% of patients, trailing Stockport's 19.7% while working ages predominate

    Across 40,645 registered patients, 16.6% (6,743) are aged 65+, below Stockport (LAD) at 19.7% and England at 17.9%, but above NHS Greater Manchester Integrated Care Board at 14.9%. Working-age adults aged 18-64 comprise 63.4% (25,749), above Stockport (LAD) at 60.6%, matching the ICB at 63.3%, and above England at 62.7%. Children aged 0-17 represent 20.1% (8,153; Stockport (LAD) 19.7%, ICB 21.8%, England 19.6%). Catchment services include 16 care homes with 716 beds. Roma residents comprise 0.1% and Gypsy or Irish Traveller 0.0%. Projected list growth to 2030 is 0.5% (Stockport (LAD) 1.1%, ICB 1.6%, England 2.3%; unverified methodology).

    Age profile

    0–1720.1%
    18–6463.4%
    65+16.6%

    65+: ICB 14.9%, England 17.9%

    Older people · falls rows are Stockport (LAD) local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Stockport LA)2,0722,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)80.9%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)56.9%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Stockport LA)9191,0219552024/25
    Falls deaths, all ages, per 100,000 (Stockport LA)23.718.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 patients comprise 23.8% of the list, spanning 32.0 percentage points across practices

    Core20 patients make up 23.8% of the PCN list, above Stockport (LAD) at 16.1% and England at 21.0%, but below NHS Greater Manchester Integrated Care Board at 40.7%, representing about 8,800 estimated residents. Deprivation spans a 32.0 pp range across practices: Adshall Road Medical Prac has the highest share at 32.0% (1,543 estimated patients), whereas Stockport Medical Group holds the largest volume at 5,356 estimated patients (30.0%). The modelled weighted practice share is 22.8%.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Adshall Road32.0% · 1,543 patients
    Stockport Medical30.0% · 5,356 patients
    Caritas General19.3% · 2,350 patients
    Bracondale0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    502

    SMI register

    1.21% recorded prevalence

    263

    Learning disability register

    0.63% recorded prevalence

    16

    Care homes, 716 beds

    In the PCN catchment

    9.5%

    Provide unpaid care

    Stockport (LAD), Census 2021

    The PCN records 502 patients on the severe mental illness register (1.2% prevalence, compared with 1.0% in Stockport (LAD), 1.1% in NHS Greater Manchester Integrated Care Board, and 1.0% in England). The learning disability register includes 263 patients (0.6% prevalence, matching Stockport (LAD), the ICB, and England at 0.6%). Higher recorded severe mental illness prevalence may increase routine physical health review demand across member practices.

    Severe mental illness: physical health checks

    SMI prevalence is 1.2% (England 1.0%). Recorded BMI checks reach 79.5% (England 82.1%, Stockport (LAD) 84.0%), with three-year progress of +1.7 pp (2023 to 2025) lagging England (+5.1 pp).

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    6,460

    Hypertension register

    +3.58%

    Register growth, 3 yrs

    Stockport (LAD) +4.99% · England +5.60%

    +0.12pp

    BP control, under 80

    ≤140/90 · −0.70pp aged 80+

    +539

    More patients by 2030

    Forecast 6,999 (16.67%)

    Hypertension case-finding and control

    Hypertension prevalence is 15.5% (6,460 patients), against 16.2% in Stockport (LAD), 14.4% in NHS Greater Manchester Integrated Care Board, and 15.2% in England. Recent blood pressure monitoring reaches 91.2% (England 90.0%), but three-year register growth of +3.6% (2023 to 2025) trails England (+5.6%) and the borough (+5.0%). Blood pressure control under age 80 stands at 69.7% (England 67.8%), though three-year progress (+0.2%, +0.1 pp) lags England (+3.2%, +2.1 pp) and the ICB (+3.6%, +2.4 pp). Caritas General Practice Partnership records 66.5% control under age 80. Plateauing blood pressure control despite high monitoring suggests an opportunity to standardise treatment titration across practices before clinical outcomes decline.

    Lipids and statins

    Lipid-lowering therapy reaches 70.8% of patients with QRISK ≥ 20%, exceeding England (63.6%) and Stockport (LAD) (64.8%). Conversely, statin coverage for diabetes without cardiovascular disease fell 2.6% over three years (2023 to 2025; England +2.1%) to 72.9% (England 73.2%). Lower primary-prevention statin use than England implies an opportunity to prioritise cardiovascular prevention in unreviewed diabetes.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202695,915£2.00£1.94£1.86£191,830
    Cardiovascular (all), 2025130,275£2.70£3.15£3.33£351,742

    In 2026, the PCN prescribed 95,915 lipid-regulating items at £2.00 per item, above England (£1.86), Stockport (LAD) (£1.99), and NHS Greater Manchester Integrated Care Board (£1.94). Across 95,915 items, this is £13,428 more than at England's unit cost. This unit-cost indicator does not establish efficiency or case-mix differences; formulary audit would test prescribing variation.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    −5.01%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    −3.65%

    Asthma prevalence, PCN 3-yr % change

    Current review completion exceeds England for COPD at 80.0% (England 76.4%) and asthma at 67.5% (England 65.7%). Over three years (2023 to 2025), reviews fell 8.1% for COPD (England +2.8%) and 5.0% for asthma (England +4.4%), leaving about 970 asthma patients without a recorded review. Asthma prescribing reaches 1,958 items per 1,000 aged 5-19 (England 1,488). Declining reviews alongside higher youth prescribing could indicate unreviewed maintenance; clinical recall audit would test this.

    Cancer register and children's immunisation

    Cancer register prevalence is 3.8% (1,592 patients, matching England at 3.8%). In Q1 2025/26, 6-in-1 coverage at 12 months reached 96.5%, meeting the 95.0% target. At age 5, MMR dose 1 reached 95.4%, but MMR dose 2 was 91.7% (below target by 3.3 pp) and 4-in-1 booster coverage was 86.2% (below target by 8.8 pp).

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months96.5%

    England 91.0%

    6-in-1 complete primary course at 24 months95.2%

    England 92.2%

    MMR dose 1 at 24 months94.2%

    England 88.3%

    MMR dose 2 at age 591.7%

    England 82.8%

    4-in-1 pre-school booster at age 586.2%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.6%

    Greater Manchester ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,270

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Greater Manchester ICBEnglandNo usable stageStaged cancers
    Lung40.4%33.8%15%2,193
    Prostate61.7%53.2%14%1,788
    Breast82.5%85.4%19%1,758
    Bowel46.3%47.0%19%1,427
    Skin cancer84.5%87.8%27%580

    In 2022, 55.6% of staged cancers in NHS Greater Manchester ICB were diagnosed at stage 1 or 2 (6,491 of 11,679), matching England (55.3%) but 19.4 pp below the 75.0% 2028 ambition. Reaching it requires about 2,270 extra early diagnoses annually; early-stage share rose 3.1 pp from 2013 to 2022. Known-stage completeness was 70.8% (11,679 of 16,492). For the PCN (1,592 cancer patients), cervical screening is 75.4% (Stockport 75.9%), trailing at Caritas General Practice Partnership (74.4%) and Stockport Medical Group (72.2%). System staging is ICB level, not PCN performance. Screening variation across practices highlights where proactive recall could support earlier cancer presentation.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In Jul 2026, Stockport NHS Foundation Trust achieved 74.7% on the 62-day cancer standard, below the 85.0% standard by 10.3 pp (Manchester University 72.8%, Tameside and Glossop 76.8%, ICB 75.7%, England 71.2%). The trust met the 28-day faster diagnosis standard at 83.2% (standard 75.0%; ICB 79.5%, England 79.3%). For diagnostics, 14.1% waited 6+ weeks at Stockport NHS Foundation Trust (Manchester University 9.0%, Tameside and Glossop 0.8%, England 23.1%), with delays in audiology (67.7%) and urodynamics (50.9%). Trust figures reflect provider activity, not PCN performance.

    Pathways within standard (%)StockportManchesterTameside and Glossop Integrated CareGreater Manchester ICBEngland
    28-day faster diagnosis (75%)83.2180.0682.4879.5379.32
    31-day treatment (96%)97.3992.5496.2596.4992.50
    62-day referral to treatment (85%)74.6772.8576.7775.7371.16
    Diagnostic waits over 6 weeks (%)StockportManchesterTameside and Glossop Integrated CareEngland
    MRI1.4111.680.0021.40
    CT2.9314.660.189.92
    Echocardiography17.464.910.0028.48
    Colonoscopy5.534.511.5130.83
    Gastroscopy5.3129.355.4529.02
    All 15 DM01 tests14.088.980.8023.14
    Community services activityStockport residentsGreater Manchester ICB
    Care contacts57,085573,310
    Referrals10,69094,470
    Patients with a contact16,950183,535

    Community services (residents of Stockport), Jun 2026 (provisional). In Jun 2026, provisional Community Services Data Set records show that 60.6% of community contacts among Stockport local authority residents were with adults aged 65 and over (34,585 of 57,085 contacts). While this demonstrates that community activity is predominantly delivered to older residents across the borough, these figures reflect resident local authority contacts rather than PCN-level provision and do not capture provider attribution.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Phone access spans 31.0 pp and vaccination achievement 71.2 pp across practices

    In 2025/26, QOF overall achievement ranged from 91.8% at Adshall Road Medical Prac to 96.2% at Stockport Medical Group (England 92.5%). Vaccination and immunisation achievement diverged by 71.2 pp, from 28.1% at Adshall Road Medical Prac to 99.3% at Bracondale Medical Centre (England 55.2%), highlighting a wide achievement span across member practices.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Bracondale1020.079.9%70.8%93.7%
    Adshall Road11932.077.1%70.7%91.8%
    Caritas General11719.363.9%70.8%89.0%
    Stockport Medical11330.048.9%75.0%75.7%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNStockport (LAD)AssetPCNStockport (LAD)
    Care homes (catchment)16 (716 beds)n/aSchools (catchment)72n/a
    Children's centres12Places of worship47135
    Libraries312Food banks (VCS)n/a1
    Primary schools (LA maintained)1761Primary academies623
    Special schools24

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Structured asthma review and prescribing recall

    Asthma reviews reach 67.5% (England 65.7%, Stockport (LAD) 63.4%), but fell 5.0% (by 3.6 pp) from 2023 to 2025 while England rose +4.4% (+2.8 pp), leaving 966 of 2,973 patients unreviewed. For discussion, practices could run a recall audit combining annual asthma reviews with inhaler prescribing checks. Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Hypertension under-80 treatment titration recall

    Blood pressure control under 80 across 6,460 patients is 69.7% (England 67.8%, Stockport (LAD) 70.8%; Caritas General Practice Partnership 66.5%), with 2023 to 2025 change at +0.2% (+0.1 pp) versus England's +3.2% (+2.1 pp). For discussion, the PCN could consider pharmacist-led recall and medicines titration for patients above threshold. Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Option 3

    Two-track Core20 access and telephony review

    In Jan-Apr 2026, easy phone contact was 48.9% at Stockport Medical Group (England 56.9%; 5,356 estimated Core20, 30.0%) versus 79.9% at Bracondale Medical Centre (31.0 pp range); Adshall Road Medical Prac has 32.0% Core20 (1,543 estimated). Moderate effort to run.

    Evidence base: the share of patients in the most deprived quintile is the Core20 targeting measure used to weight inequalities funding, outreach and prevention capacity, and the gradient every clinical indicator should be read against.

    Policy anchor: Core20PLUS5 (Core20 = the most deprived 20% by IMD); 10 Year Health Plan, with widening inequalities the equity test of reform.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Care home clinical review coordination (p2)Count of Care Homes in PCN catchmentFit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework: revenue finance and contracting guidance 2026PCN
    Two-track Core20 outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI physical health recall (p4)SMI register with a BMI recorded in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertension control audit (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school booster catch-up audit (p6)4-in-1 pre-school booster (DTaP/IPV) coverage at age 510YHP sickness to prevention · 95% targetPCN
    Screening uptake and early presentation (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Practice telephony and triage review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · Structured asthma review and prescribing recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · Asthma management items prescribed per 1000 5-19 PopulationCore20PLUS5 respiratoryPCN
    Option 2 · Hypertension under-80 treatment titration recall (p12)Hypertension register · Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs) · Hypertension patients with a recent BP readingCore20PLUS5 CVD · CVDPREVENT 2029PCN & Practice
    Option 3 · Two-track Core20 access and telephony review (p12)Core20 cohort (IMD quintile 1) · GPPS easy to contact the practice by phone · GPPS easy to contact the practice using its websiteCore20PLUS5 · 10YHP equity test · 10YHP, hospital to communityPCN & Practice
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15